| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cell and Tumor Biology |
1 Department of Life Science, Division of Molecular Life Sciences and Center for Cell Signaling Research, Ewha Womans University; 2 Department of Bioscience and Biotechnology, Institute of Bioscience, Sejong University, Seoul, Korea; and 3 Department of Physiology and Biophysics, Inha University, Incheon, Korea
Requests for reprints: Eok-Soo Oh, Center for Cell Signaling Research, Ewha Womans University, Daehyun-dong, Seodaemoon-Gu, Seoul 120-750, Korea. Phone: 82-2-3277-3761; Fax: 82-2-3277-3760; E-mail: OhES{at}ewha.ac.kr.
Expression of syndecan-2, a transmembrane heparan sulfate proteoglycan, is crucial for the tumorigenic activity in colon carcinoma cells. However, despite the high-level expression of syndecan-2 in mesenchymal cells, few studies have addressed the function of syndecan-2 in sarcoma cells. In HT1080 fibrosarcoma cells, we found that syndecan-2 regulated migration, invasion into Matrigel, and anchorage-independent growth but not cell-extracellular matrix adhesion or proliferation, suggesting that syndecan-2 plays different functional roles in fibrosarcoma and colon carcinoma cells. Consistent with the increased cell migration/invasion of syndecan-2overexpressing HT1080 cells, syndecan-2 overexpression increased phosphorylation and interaction of focal adhesion kinase (FAK) and phosphatidylinositol 3-kinase (PI3K), membrane localization of T-lymphoma invasion and metastasis gene-1 (Tiam-1), and activation of Rac. Syndecan-2mediated cell migration/invasion of HT1080 cells was diminished when (a) cells were cotransfected with nonphosphorylatable mutant FAK Y397F or with other FAK mutants lacking PI3K interactions, (b) cells were treated with a specific PI3K inhibitor, or (c) levels of Tiam-1 were knocked down with small interfering RNAs. Furthermore, expression of several FAK mutants inhibited syndecan-2mediated enhancement of anchorage-independent growth in HT1080 cells. Taken together, these data suggest that syndecan-2 regulates the tumorigenic activities of HT1080 fibrosarcoma cells and that FAK is a key regulator of syndecan-2mediated tumorigenic activities.
This article has been cited by other articles:
![]() |
J.-h. Lee, H. Park, H. Chung, S. Choi, Y. Kim, H. Yoo, T.-Y. Kim, H.-J. Hann, I. Seong, J. Kim, et al. Syndecan-2 Regulates the Migratory Potential of Melanoma Cells J. Biol. Chem., October 2, 2009; 284(40): 27167 - 27175. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Araki, Y. Momota, T. Togo, M. Tanioka, K. Hozumi, M. Nomizu, Y. Miyachi, and A. Utani Clustering of Syndecan-4 and Integrin {beta}1 by Laminin {alpha}3 Chain-derived Peptide Promotes Keratinocyte Migration Mol. Biol. Cell, July 1, 2009; 20(13): 3012 - 3024. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Orosco, O. Fromigue, C. Bazille, N. Entz-Werle, P. Levillain, P. J. Marie, and D. Modrowski Syndecan-2 Affects the Basal and Chemotherapy-Induced Apoptosis in Osteosarcoma Cancer Res., April 15, 2007; 67(8): 3708 - 3715. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sutton, V. Friand, S. Brule-Donneger, T. Chaigneau, M. Ziol, O. Sainte-Catherine, A. Poire, L. Saffar, M. Kraemer, J. Vassy, et al. Stromal Cell-Derived Factor-1/Chemokine (C-X-C Motif) Ligand 12 Stimulates Human Hepatoma Cell Growth, Migration, and Invasion Mol. Cancer Res., January 1, 2007; 5(1): 21 - 33. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |